{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T15:45:00Z","timestamp":1786981500075,"version":"build-2736575974"},"reference-count":84,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T00:00:00Z","timestamp":1779926400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T00:00:00Z","timestamp":1779926400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"National Network Project","award":["BT\/PR40195\/BTIS\/137\/58\/2023"],"award-info":[{"award-number":["BT\/PR40195\/BTIS\/137\/58\/2023"]}]},{"name":"Institute of Eminence, University of Delhi","award":["Grant No. IoE\/ 2023-24\/ 12\/ FRP"],"award-info":[{"award-number":["Grant No. IoE\/ 2023-24\/ 12\/ FRP"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Metab Brain Dis"],"DOI":"10.1007\/s11011-026-01887-9","type":"journal-article","created":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T09:08:01Z","timestamp":1779959281000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["TTP protects against 6-OHDA-induced dopaminergic neurodegeneration via astrocytic Nrf2\/HO-1 activation in cellular and rat models of Parkinson\u2019s disease"],"prefix":"10.1007","volume":"41","author":[{"ORCID":"https:\/\/orcid.org\/0009-0005-6952-1853","authenticated-orcid":false,"given":"Ankit","family":"Singh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jyoti","family":"Mishra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madhu","family":"Chopra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pratibha Mehta","family":"Luthra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,28]]},"reference":[{"key":"1887_CR1","doi-asserted-by":"publisher","first-page":"e202404742","DOI":"10.1002\/slct.202404742","volume":"10","author":"A Anjali, Mishra","year":"2025","unstructured":"Anjali, Mishra A, Khurana M, Pani B, Awasthi SK (2025) Recent advances in functionalization of graphene oxide and its role in catalytic organic transformations: a comprehensive review (2018\u20132024). ChemistrySelect 10:e202404742","journal-title":"ChemistrySelect"},{"key":"1887_CR2","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1007\/s11064-024-04319-1","volume":"50","author":"M Aqeel","year":"2025","unstructured":"Aqeel M, Upadhayay S, Devi R, Jangid K, Kumar V, Kumar P (2025) Glycyrrhizic acid mitigates haloperidol-induced neurotoxicity in SHSY-5Y cells and rats via activation of PI3k\/Akt\/Nrf2 pathways. Neurochem Res 50:75","journal-title":"Neurochem Res"},{"key":"1887_CR3","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1016\/j.pharmthera.2011.07.004","volume":"132","author":"MT Armentero","year":"2011","unstructured":"Armentero MT, Pinna A, Ferr\u00e9 S, Lanciego JL, M\u00fcller CE, Franco R (2011) Past, present and future of A2A adenosine receptor antagonists in the therapy of Parkinson\u2019s disease. Pharmacol Ther 132:280\u2013299","journal-title":"Pharmacol Ther"},{"key":"1887_CR4","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1007\/s00204-011-0674-5","volume":"85","author":"L Baird","year":"2011","unstructured":"Baird L, Dinkova-Kostova AT (2011) The cytoprotective role of the Keap1\u2013Nrf2 pathway. Arch Toxicol 85:241\u2013272","journal-title":"Arch Toxicol"},{"key":"1887_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.neulet.2010.08.006","volume":"488","author":"SK Barodia","year":"2011","unstructured":"Barodia SK, Mishra CB, Prakash A, Kumar JS, Kumari N, Luthra PM (2011) Novel 8-(furan-2-yl)-3-benzyl thiazolo [5, 4-e][1, 2, 4] triazolo [1, 5-c] pyrimidine-2 (3H)-thione as selective adenosine A2A receptor antagonist. Neurosci Lett 488:1\u20135","journal-title":"Neurosci Lett"},{"key":"1887_CR6","doi-asserted-by":"publisher","first-page":"142","DOI":"10.3390\/biom9040142","volume":"9","author":"FD Bello","year":"2019","unstructured":"Bello FD, Giannella M, Giorgioni G, Piergentili A, Quaglia W (2019) Receptor ligands as helping hands to L-DOPA in the treatment of Parkinson\u2019s disease. Biomolecules 9:142","journal-title":"Biomolecules"},{"key":"1887_CR7","doi-asserted-by":"publisher","first-page":"S229","DOI":"10.1067\/mai.2002.129370","volume":"110","author":"JL Benovic","year":"2002","unstructured":"Benovic JL (2002) Novel \u03b22-adrenergic receptor signaling pathways. J allergy Clin Immunol 110:S229\u2013S235","journal-title":"J allergy Clin Immunol"},{"key":"1887_CR8","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1186\/s13104-015-1228-3","volume":"8","author":"MZ Bhatti","year":"2015","unstructured":"Bhatti MZ, Ali A, Ahmad A, Saeed A, Malik SA (2015) Antioxidant and phytochemical analysis of Ranunculus arvensis L. extracts. BMC Res Notes 8:279","journal-title":"BMC Res Notes"},{"key":"1887_CR9","doi-asserted-by":"publisher","first-page":"1731","DOI":"10.1007\/s00228-020-02961-6","volume":"76","author":"CD Binde","year":"2020","unstructured":"Binde CD, Tvete IF, G\u00e5semyr JI, Natvig B, Klemp M (2020) Comparative effectiveness of dopamine agonists and monoamine oxidase type-B inhibitors for Parkinson\u2019s disease: a multiple treatment comparison meta-analysis. Eur J Clin Pharmacol 76:1731\u20131743","journal-title":"Eur J Clin Pharmacol"},{"key":"1887_CR10","doi-asserted-by":"publisher","first-page":"43","DOI":"10.3389\/fnins.2018.00043","volume":"12","author":"DO Borroto-Escuela","year":"2018","unstructured":"Borroto-Escuela DO, Hinz S, Navarro G, Franco R, M\u00fcller CE, Fuxe K (2018) Understanding the role of adenosine A2AR heteroreceptor complexes in neurodegeneration and neuroinflammation. Front NeuroSci 12:43","journal-title":"Front NeuroSci"},{"key":"1887_CR11","doi-asserted-by":"publisher","first-page":"443","DOI":"10.3389\/fcell.2020.00443","volume":"8","author":"T Cardoso","year":"2020","unstructured":"Cardoso T, L\u00e9vesque M (2020) Toward generating subtype-specific mesencephalic dopaminergic neurons in vitro. Front Cell Dev Biology 8:443","journal-title":"Front Cell Dev Biology"},{"key":"1887_CR12","doi-asserted-by":"publisher","first-page":"1617106","DOI":"10.3389\/fnagi.2025.1617106","volume":"17","author":"SA Chaudhary","year":"2025","unstructured":"Chaudhary SA, Chaudhary S, Rawat S (2025) Understanding Parkinson\u2019s Disease: Current Trends and its Multifaceted Complications. Front Aging Neurosci 17:1617106","journal-title":"Front Aging Neurosci"},{"key":"1887_CR13","doi-asserted-by":"publisher","first-page":"1970","DOI":"10.1073\/pnas.98.4.1970","volume":"98","author":"J-F Chen","year":"2001","unstructured":"Chen J-F, Moratalla R, Impagnatiello F, Grandy DK, Cuellar B, Rubinstein M, Beilstein MA, Hackett E, Fink JS, Low MJ (2001) The role of the D2 dopamine receptor (D2R) in A2A adenosine receptor (A2AR)-mediated behavioral and cellular responses as revealed by A2A and D2 receptor knockout mice. Proc Natl Acad Sci 98:1970\u20131975","journal-title":"Proc Natl Acad Sci"},{"key":"1887_CR14","doi-asserted-by":"publisher","first-page":"H1862","DOI":"10.1152\/ajpheart.00651.2005","volume":"290","author":"X-L Chen","year":"2006","unstructured":"Chen X-L, Dodd G, Thomas S, Zhang X, Wasserman MA, Rovin BH, Kunsch C (2006) Activation of Nrf2\/ARE pathway protects endothelial cells from oxidant injury and inhibits inflammatory gene expression. Am J Physiol Heart Circ Physiol 290:H1862\u2013H1870","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"1887_CR15","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1111\/jnc.13724","volume":"139","author":"RA Cunha","year":"2016","unstructured":"Cunha RA (2016) How does adenosine control neuronal dysfunction and neurodegeneration? J Neurochem 139:1019\u20131055","journal-title":"J Neurochem"},{"key":"1887_CR16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.abb.2010.12.017","volume":"508","author":"SC Daubner","year":"2011","unstructured":"Daubner SC, Le T, Wang S (2011) Tyrosine hydroxylase and regulation of dopamine synthesis. Arch Biochem Biophys 508:1\u201312","journal-title":"Arch Biochem Biophys"},{"key":"1887_CR17","doi-asserted-by":"crossref","unstructured":"Giudice A, Arra C, Turco MC (2010) Review of molecular mechanisms involved in the activation of the Nrf2-ARE signaling pathway by chemopreventive agents. Transcript Fact Methods Prot 37\u201374","DOI":"10.1007\/978-1-60761-738-9_3"},{"key":"1887_CR18","doi-asserted-by":"publisher","first-page":"116","DOI":"10.3389\/fnmol.2020.00116","volume":"13","author":"MA Hannan","year":"2020","unstructured":"Hannan MA, Dash R, Sohag AAM, Haque MN, Moon IS (2020) Neuroprotection against oxidative stress: Phytochemicals targeting TrkB signaling and the Nrf2-ARE antioxidant system. Front Mol Neurosci 13:116","journal-title":"Front Mol Neurosci"},{"key":"1887_CR19","doi-asserted-by":"publisher","first-page":"4777","DOI":"10.3390\/ijms21134777","volume":"21","author":"F He","year":"2020","unstructured":"He F, Ru X, Wen T (2020) NRF2, a transcription factor for stress response and beyond. Int J Mol Sci 21:4777","journal-title":"Int J Mol Sci"},{"key":"1887_CR20","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1007\/s11910-012-0279-2","volume":"12","author":"P Hickey","year":"2012","unstructured":"Hickey P, Stacy M (2012) Adenosine A2A antagonists in Parkinson\u2019s disease: what\u2019s next? Curr Neurol Neurosci Rep 12:376\u2013385","journal-title":"Curr Neurol Neurosci Rep"},{"key":"1887_CR22","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1124\/jpet.108.149617","volume":"330","author":"RA Hodgson","year":"2009","unstructured":"Hodgson RA, Bertorelli R, Varty GB, Lachowicz JE, Forlani A, Fredduzzi S, Cohen-Williams ME, Higgins GA, Impagnatiello F, Nicolussi E (2009) Characterization of the potent and highly selective A2A receptor antagonists preladenant and SCH 412348 [7-[2-[4\u2009\u2013\u20092, 4-difluorophenyl]-1-piperazinyl] ethyl]-2-(2-furanyl)-7H-pyrazolo [4, 3-e][1, 2, 4] triazolo [1, 5-c] pyrimidin-5-amine] in rodent models of movement disorders and depression. J Pharmacol Exp Ther 330:294\u2013303","journal-title":"J Pharmacol Exp Ther"},{"key":"1887_CR21","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1016\/j.expneurol.2010.07.011","volume":"225","author":"RA Hodgson","year":"2010","unstructured":"Hodgson RA, Bedard PJ, Varty GB, Kazdoba TM, Paolo DI, Grzelak T, Pond ME, Hadjtahar AJ, Belanger A, N., Gregoire L (2010) Preladenant, a selective A2A receptor antagonist, is active in primate models of movement disorders. Exp Neurol 225:384\u2013390","journal-title":"Exp Neurol"},{"key":"1887_CR23","doi-asserted-by":"publisher","first-page":"902","DOI":"10.3390\/antiox9090902","volume":"9","author":"M Ikram","year":"2020","unstructured":"Ikram M, Park TJ, Ali T, Kim MO (2020) Antioxidant and neuroprotective effects of caffeine against Alzheimer\u2019s and Parkinson\u2019s disease: Insight into the role of Nrf-2 and A2AR signaling. Antioxidants 9:902","journal-title":"Antioxidants"},{"key":"1887_CR24","doi-asserted-by":"publisher","first-page":"2892","DOI":"10.2174\/1381612825666190716112319","volume":"25","author":"S Jamwal","year":"2019","unstructured":"Jamwal S, Mittal A, Kumar P, Alhayani DM, Al-Aboudi A (2019) Therapeutic potential of agonists and antagonists of A1, A2a, A2b and A3 adenosine receptors. Curr Pharm Design 25:2892\u20132905","journal-title":"Curr Pharm Design"},{"key":"1887_CR25","doi-asserted-by":"crossref","unstructured":"Jellinger KA (2011) Parkinson\u2019s disease. Neurodegeneration Mol Pathol Dement Mov Disord 194\u2013223","DOI":"10.1002\/9781444341256.ch21"},{"key":"1887_CR26","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1080\/14737175.2021.1880896","volume":"21","author":"P Jenner","year":"2021","unstructured":"Jenner P, Mori A, Aradi SD, Hauser RA (2021) Istradefylline\u2013a first generation adenosine A2A antagonist for the treatment of Parkinson\u2019s disease. Expert Rev Neurother 21:317\u2013333","journal-title":"Expert Rev Neurother"},{"key":"1887_CR27","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1007\/s10072-018-3585-x","volume":"40","author":"R Kaur","year":"2019","unstructured":"Kaur R, Mehan S, Singh S (2019) Understanding multifactorial architecture of Parkinson\u2019s disease: pathophysiology to management. Neurol Sci 40:13\u201323","journal-title":"Neurol Sci"},{"key":"1887_CR28","doi-asserted-by":"crossref","unstructured":"Khurana M, Awasthi SK (2025) Metal\u2013organic frameworks as catalytic platforms for multicomponent reactions (MCRs): mechanistic and design insights (2020\u20132025 overview). Catal Sci Technol","DOI":"10.1039\/D5CY00829H"},{"key":"1887_CR29","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1021\/acssuschemeng.4c04579","volume":"13","author":"M Khurana","year":"2025","unstructured":"Khurana M, Mittal R, Kumari L, Awasthi SK (2025) Enhanced Catalytic Activity of the Metal Oxide-Incorporated Metal Organic Framework Composite (Mn3O4@ ZIF-67) in the Acetylation Reaction of Amines and Alcohols. ACS Sustain Chem Eng 13:754\u2013766","journal-title":"ACS Sustain Chem Eng"},{"key":"1887_CR30","doi-asserted-by":"publisher","first-page":"e2942","DOI":"10.1002\/btpr.2942","volume":"36","author":"KR Ko","year":"2020","unstructured":"Ko KR, Tam NW, Teixeira AG, Frampton JP (2020) SH-SY5Y and LUHMES cells display differential sensitivity to MPP+, tunicamycin, and epoxomicin in 2D and 3D cell culture. Biotechnol Prog 36:e2942","journal-title":"Biotechnol Prog"},{"key":"1887_CR34","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.neulet.2014.12.030","volume":"589","author":"R Kumari","year":"2015","unstructured":"Kumari R, Kumar JS, Luthra PM (2015) Post-lesion administration of 7-NI attenuated motor and non-motor deficits in 6-OHDA induced bilaterally lesioned female rat model of Parkinson\u2019s disease. Neurosci Lett 589:191\u2013195","journal-title":"Neurosci Lett"},{"key":"1887_CR33","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.neulet.2017.03.033","volume":"647","author":"N Kumari","year":"2017","unstructured":"Kumari N, Agrawal S, Luthra PM (2017) Pharmacological assessments of potent A2A receptor antagonist IDPU (1-(7-imino-3-propyl-2, 3-dihydrothiazolo [4, 5-d] pyrimidin-6 (7H)-yl) urea) in rodent model of haloperidol induced Parkinson like symptoms. Neurosci Lett 647:53\u201360","journal-title":"Neurosci Lett"},{"key":"1887_CR32","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.neulet.2018.03.040","volume":"675","author":"N Kumari","year":"2018","unstructured":"Kumari N, Agrawal S, Kumari R, Sharma D, Luthra PM (2018) Neuroprotective effect of IDPU (1-(7-imino-3-propyl-2, 3-dihydrothiazolo [4, 5-d] pyrimidin-6 (7H)-yl) urea) in 6-OHDA induced rodent model of hemiparkinson\u2019s disease. Neurosci Lett 675:74\u201382","journal-title":"Neurosci Lett"},{"key":"1887_CR31","doi-asserted-by":"publisher","first-page":"19500","DOI":"10.1039\/D5RA02165K","volume":"15","author":"L Kumari","year":"2025","unstructured":"Kumari L, Mittal R, Khurana M, Awasthi SK (2025) Synthesis and structural analysis of a ZIF-9\/GO composite for green catalytic C\u2013C bond formation and N-formylation: a spectroscopic study. RSC Adv 15:19500\u201319514","journal-title":"RSC Adv"},{"key":"1887_CR35","doi-asserted-by":"publisher","first-page":"918","DOI":"10.3390\/biomedicines9080918","volume":"9","author":"H-C Kung","year":"2021","unstructured":"Kung H-C, Lin K-J, Kung C-T, Lin T-K (2021) Oxidative stress, mitochondrial dysfunction, and neuroprotection of polyphenols with respect to resveratrol in Parkinson\u2019s disease. Biomedicines 9:918","journal-title":"Biomedicines"},{"key":"1887_CR36","doi-asserted-by":"publisher","first-page":"4780","DOI":"10.2174\/0929867329666220218094501","volume":"29","author":"C Lambertucci","year":"2022","unstructured":"Lambertucci C, Marucci G, Catarzi D, Colotta V, Francucci B, Spinaci A, Varano F, Volpini R (2022) A2A; adenosine receptor antagonists and their potential in neurological disorders. Curr Med Chem 29:4780\u20134795","journal-title":"Curr Med Chem"},{"key":"1887_CR37","doi-asserted-by":"crossref","unstructured":"Lee CR, Tepper JM (2009) Basal ganglia control of substantia nigra dopaminergic neurons. Birth Life Death Dopaminergic Neurons Substantia Nigra 71\u201390","DOI":"10.1007\/978-3-211-92660-4_6"},{"key":"1887_CR38","doi-asserted-by":"crossref","unstructured":"Lenaz G (2011) Mitochondria and reactive oxygen species. Which role in physiology and pathology? Adv Mitochondrial Med 93\u2013136","DOI":"10.1007\/978-94-007-2869-1_5"},{"key":"1887_CR39","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1186\/s40001-024-02028-7","volume":"29","author":"W Liu","year":"2024","unstructured":"Liu W, Li Q, Fang W, Wang CAIL, Kou Z, Zhou B, Zhou C, Yao Y, Z., Wei M (2024) A2AR regulate inflammation through PKA\/NF-\u03baB signaling pathways in intervertebral disc degeneration. Eur J Med Res 29:433","journal-title":"Eur J Med Res"},{"key":"1887_CR41","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.neulet.2009.07.085","volume":"463","author":"PM Luthra","year":"2009","unstructured":"Luthra PM, Prakash A, Barodia SK, Kumari R, Mishra CB, Kumar JS (2009) In silico study of naphtha [1, 2-d] thiazol-2-amine with adenosine A2A receptor and its role in antagonism of haloperidol-induced motor impairments in mice. Neurosci Lett 463:215\u2013218","journal-title":"Neurosci Lett"},{"key":"1887_CR40","doi-asserted-by":"publisher","first-page":"1214","DOI":"10.1016\/j.bmcl.2009.11.133","volume":"20","author":"PM Luthra","year":"2010","unstructured":"Luthra PM, Mishra CB, Jha PK, Barodia SK (2010) Synthesis of novel 7-imino-2-thioxo-3, 7-dihydro-2H-thiazolo [4, 5-d] pyrimidine derivatives as adenosine A2A receptor antagonists. Bioorg Med Chem Lett 20:1214\u20131218","journal-title":"Bioorg Med Chem Lett"},{"key":"1887_CR42","first-page":"9832839","volume":"2016","author":"F Magrinelli","year":"2016","unstructured":"Magrinelli F, Picelli A, Tocco P, Federico A, Roncari L, Smania N, Zanette G, Tamburin S (2016) Pathophysiology of motor dysfunction in Parkinson\u2019s disease as the rationale for drug treatment and rehabilitation. Parkinson\u2019s Dis 2016.","journal-title":"Parkinson\u2019s Dis"},{"key":"1887_CR43","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/s40035-017-0099-z","volume":"6","author":"P Maiti","year":"2017","unstructured":"Maiti P, Manna J, Dunbar GL (2017) Current understanding of the molecular mechanisms in Parkinson\u2019s disease: targets for potential treatments. Translational neurodegeneration 6:28","journal-title":"Translational neurodegeneration"},{"key":"1887_CR44","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1111\/j.1432-1033.1974.tb03714.x","volume":"47","author":"S Marklund","year":"1974","unstructured":"Marklund S, Marklund G (1974) Involvement of the superoxide anion radical in the autoxidation of pyrogallol and a convenient assay for superoxide dismutase. Eur J Biochem 47:469\u2013474","journal-title":"Eur J Biochem"},{"key":"1887_CR45","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1038\/s41419-020-03056-x","volume":"11","author":"L Mele","year":"2020","unstructured":"Mele L, Del Vecchio V, Marampon F, Regad T, Wagner S, Mosca L, Bimonte S, Giudice A, Liccardo D, Prisco C (2020) \u03b22-AR blockade potentiates MEK1\/2 inhibitor effect on HNSCC by regulating the Nrf2-mediated defense mechanism. Cell Death Dis 11:850","journal-title":"Cell Death Dis"},{"key":"1887_CR46","doi-asserted-by":"publisher","first-page":"2491","DOI":"10.1016\/j.bmc.2010.02.048","volume":"18","author":"CB Mishra","year":"2010","unstructured":"Mishra CB, Barodia SK, Prakash A, Kumar JS, Luthra PM (2010) Novel 8-(furan-2-yl)-3-substituted thiazolo [5, 4-e][1, 2, 4] triazolo [1, 5-c] pyrimidine-2 (3H)-thione derivatives as potential adenosine A2A receptor antagonists. Bioorg Med Chem 18:2491\u20132500","journal-title":"Bioorg Med Chem"},{"key":"1887_CR47","doi-asserted-by":"publisher","first-page":"6077","DOI":"10.1016\/j.bmc.2013.07.005","volume":"21","author":"CB Mishra","year":"2013","unstructured":"Mishra CB, Sharma D, Prakash A, Kumari N, Kumar N, Luthra PM (2013) Design and synthesis of (4E)-4-(4-substitutedbenzylideneamino)-3-substituted-2, 3-dihydro-2-thioxothiazole-5-carbonitrile as novel A2A receptor antagonists. Bioorg Med Chem 21:6077\u20136083","journal-title":"Bioorg Med Chem"},{"key":"1887_CR48","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.neuro.2024.08.008","volume":"105","author":"J Mishra","year":"2024","unstructured":"Mishra J, Walecha V, Sophronea T, Singh A, Agrawal S, Luthra PM (2024) BBPT attenuated 6-OHDA-induced toxicity by modulating oxidative stress, apoptotic, and inflammatory proteins in primary neurons and rat models of Parkinson\u2019s disease. Neurotoxicology 105:67\u201381","journal-title":"Neurotoxicology"},{"key":"1887_CR49","doi-asserted-by":"publisher","first-page":"2366","DOI":"10.3390\/molecules27072366","volume":"27","author":"A Mori","year":"2022","unstructured":"Mori A, Chen J-F, Uchida S, Durlach C, King SM, Jenner P (2022) The pharmacological potential of adenosine A2A receptor antagonists for treating Parkinson\u2019s disease. Molecules 27:2366","journal-title":"Molecules"},{"key":"1887_CR50","doi-asserted-by":"crossref","unstructured":"Mukherjee R, Rana R, Mehan S, Khan Z, Das Gupta G, Narula AS, Samant R (2025) Investigating the interplay between the Nrf2\/Keap1\/HO-1\/SIRT-1 pathway and the p75NTR\/PI3K\/Akt\/MAPK cascade in neurological disorders: mechanistic insights and therapeutic innovations. Mol Neurobiol 1\u201350","DOI":"10.1007\/s12035-025-04725-8"},{"key":"1887_CR51","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1007\/s00203-025-04543-5","volume":"208","author":"N Panwar","year":"2026","unstructured":"Panwar N, Singh R, Singh S, Tiwari M, Luthra PM (2026) Antibacterial and antibiofilm efficacy of ar-turmerone derived from Curcuma longa L. arrested multidrug-resistant pathogenic Gram-positive bacteria. Arch Microbiol 208:22","journal-title":"Arch Microbiol"},{"key":"1887_CR52","doi-asserted-by":"publisher","first-page":"450","DOI":"10.2174\/187152712800792910","volume":"11","author":"A Petithomme Feve","year":"2012","unstructured":"Petithomme Feve A (2012) Current status of tyrosine hydroxylase in management of Parkinson\u2019s disease. CNS Neurol Disord Drug Targets Neurol Disord 11:450\u2013455","journal-title":"CNS Neurol Disord Drug Targets Neurol Disord"},{"key":"1887_CR53","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1016\/0306-4522(95)00168-I","volume":"68","author":"A Pollack","year":"1995","unstructured":"Pollack A, Fink J (1995) Adenosine antagonists potentiate D2 dopamine-dependent activation of Fos in the striatopallidal pathway. Neuroscience 68:721\u2013728","journal-title":"Neuroscience"},{"key":"1887_CR54","doi-asserted-by":"publisher","first-page":"852","DOI":"10.2174\/1871527322666230609141519","volume":"23","author":"A Rasool","year":"2024","unstructured":"Rasool A, Manzoor R, Ullah K, Afzal R, Ul-Haq A, Imran H, Kaleem I, Akhtar T, Farrukh A, Hameed S (2024) Oxidative stress and dopaminergic metabolism: a major PD pathogenic mechanism and basis of potential antioxidant therapies. CNS Neurol Disord Drug Targets CNS Neurol Disord 23:852\u2013864","journal-title":"CNS Neurol Disord Drug Targets CNS Neurol Disord"},{"key":"1887_CR55","doi-asserted-by":"publisher","first-page":"S12","DOI":"10.1212\/01.WNL.0000095205.33940.99","volume":"61","author":"DL Rosin","year":"2003","unstructured":"Rosin DL, Hettinger BD, Lee A, Linden J (2003) Anatomy of adenosine A2A receptors in brain: morphological substrates for integration of striatal function. Neurology 61:S12\u2013S18","journal-title":"Neurology"},{"key":"1887_CR56","doi-asserted-by":"publisher","first-page":"787258","DOI":"10.3389\/fncel.2021.787258","volume":"15","author":"S Saha","year":"2022","unstructured":"Saha S, Buttari B, Profumo E, Tucci P, Saso L (2022) A perspective on Nrf2 signaling pathway for neuroinflammation: a potential therapeutic target in Alzheimer\u2019s and Parkinson\u2019s diseases. Front Cell Neurosci 15:787258","journal-title":"Front Cell Neurosci"},{"key":"1887_CR57","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1007\/s00210-013-0897-5","volume":"386","author":"M Saki","year":"2013","unstructured":"Saki M, Yamada K, Koshimura E, Sasaki K, Kanda T (2013) In vitro pharmacological profile of the A2A receptor antagonist istradefylline. Naunyn Schmiedebergs Arch Pharmacol 386:963\u2013972","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"1887_CR58","doi-asserted-by":"publisher","first-page":"904","DOI":"10.3390\/ijms17060904","volume":"17","author":"S Sarkar","year":"2016","unstructured":"Sarkar S, Raymick J, Imam S (2016) Neuroprotective and therapeutic strategies against Parkinson\u2019s disease: recent perspectives. Int J Mol Sci 17:904","journal-title":"Int J Mol Sci"},{"key":"1887_CR59","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00204-016-1805-9","volume":"91","author":"BZ Schmidt","year":"2017","unstructured":"Schmidt BZ, Lehmann M, Gutbier S, Nembo E, Noel S, Smirnova L, Forsby A, Hescheler J, Avci HX, Hartung T (2017) In vitro acute and developmental neurotoxicity screening: an overview of cellular platforms and high-throughput technical possibilities. Arch Toxicol 91:1\u201333","journal-title":"Arch Toxicol"},{"key":"1887_CR60","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1007\/s00441-004-0938-y","volume":"318","author":"A Schober","year":"2004","unstructured":"Schober A (2004) Classic toxin-induced animal models of Parkinson\u2019s disease: 6-OHDA and MPTP. Cell Tissue Res 318:215\u2013224","journal-title":"Cell Tissue Res"},{"key":"1887_CR61","doi-asserted-by":"crossref","unstructured":"Sebastiao AM, Ribeiro JA (2009) Adenosine receptors and the central nervous system. Adenosine receptors health disease, 471\u2013534","DOI":"10.1007\/978-3-540-89615-9_16"},{"key":"1887_CR62","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1007\/s11033-025-10987-1","volume":"52","author":"B Sharma","year":"2025","unstructured":"Sharma B, Lal N, Dixit K, Niharika, Singh LR, Luthra PM (2025) Demethoxycurcumin induces apoptosis and reduces cell migration by affecting AKT\/mTOR-dependent autophagy in human glioma U87MG and T98G cell lines. Mol Biol Rep 52:872","journal-title":"Mol Biol Rep"},{"key":"1887_CR63","doi-asserted-by":"publisher","first-page":"506","DOI":"10.3390\/genes13030506","volume":"13","author":"V Shrivastava","year":"2022","unstructured":"Shrivastava V, Dey D, Singal CMS, Jaiswal P, Singh A, Sharma JB, Chattopadhyay P, Nayak NR, Palanichamy JK, Sinha S (2022) Glutamate uptake is not impaired by hypoxia in a culture model of human fetal neural stem cell-derived astrocytes. Genes 13:506","journal-title":"Genes"},{"key":"1887_CR64","doi-asserted-by":"publisher","first-page":"e01357","DOI":"10.1002\/slct.202501357","volume":"10","author":"A Singh","year":"2025","unstructured":"Singh A, Khurana M, Mishra A, Pani B, Awasthi SK (2025a) Nickel-guanidine functionalized graphene oxide as a heterogeneous catalyst for the reduction of nitro compounds to amines at room temperature. ChemistrySelect 10:e01357","journal-title":"ChemistrySelect"},{"key":"1887_CR65","doi-asserted-by":"crossref","unstructured":"Singh A, Prakash A, Mishra J, Luthra PM (2025b) Discovery of novel A2AR antagonist via 3D-QSAR pharmacophore modeling: neuroprotective effects in 6-OHDA-induced SH-SY5Y cells and haloperidol-induced Parkinsonism in C57 bl\/6 mice. Mol Divers 1\u201329","DOI":"10.1007\/s11030-025-11120-x"},{"key":"1887_CR67","doi-asserted-by":"publisher","first-page":"2921","DOI":"10.1007\/s10787-024-01510-2","volume":"32","author":"D Soni","year":"2024","unstructured":"Soni D, Upadhayay S, Dhureja M, Arthur R, Kumar P, Soni et al (2024) Inflammopharmacology, 32, 2921\u20132941","journal-title":"Inflammopharmacology"},{"key":"1887_CR66","doi-asserted-by":"publisher","first-page":"177523","DOI":"10.1016\/j.ejphar.2025.177523","volume":"998","author":"D Soni","year":"2025","unstructured":"Soni D, Garg Y, Upadhayay S, Bhatia A, Basir B, Singh SK, Dua K, Kumar P (2025) Auranofin-loaded chitosan-lipid hybrid nanoparticle protects against rotenone model of Parkinson\u2019s disease via modulation of GSK-3\u03b2\/Nrf2\/HO-1 signaling. Eur J Pharmacol 998:177523","journal-title":"Eur J Pharmacol"},{"key":"1887_CR68","doi-asserted-by":"publisher","first-page":"105793","DOI":"10.1016\/j.neuint.2024.105793","volume":"178","author":"T Sophronea","year":"2024","unstructured":"Sophronea T, Agrawal S, Kumari N, Mishra J, Walecha V, Luthra PM (2024) A2AR antagonists triggered the AMPK\/m-TOR autophagic pathway to reverse the calcium-dependent cell damage in 6-OHDA induced model of PD. Neurochem Int 178:105793","journal-title":"Neurochem Int"},{"key":"1887_CR69","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/j.ejps.2015.10.017","volume":"81","author":"T Srdic-Rajic","year":"2016","unstructured":"Srdic-Rajic T, Nikolic K, Cavic M, Djokic I, Gemovic B, Perovic V, Veljkovic N (2016) Rilmenidine suppresses proliferation and promotes apoptosis via the mitochondrial pathway in human leukemic K562 cells. Eur J Pharm Sci 81:172\u2013180","journal-title":"Eur J Pharm Sci"},{"key":"1887_CR70","doi-asserted-by":"publisher","first-page":"1526","DOI":"10.1055\/s-0028-1088302","volume":"74","author":"Y-J Surh","year":"2008","unstructured":"Surh Y-J, Kundu JK, Na H-K (2008) Nrf2 as a master redox switch in turning on the cellular signaling involved in the induction of cytoprotective genes by some chemopreventive phytochemicals. Planta Med 74:1526\u20131539","journal-title":"Planta Med"},{"key":"1887_CR71","doi-asserted-by":"publisher","first-page":"395","DOI":"10.2174\/187152712800792785","volume":"11","author":"S Tabrez","year":"2012","unstructured":"Tabrez S, Jabir R, Shakil S, Greig NH, ALAM Q, Abuzenadah AM, Damanhouri GA, Kamal MA (2012) A synopsis on the role of tyrosine hydroxylase in Parkinson\u2019s disease. CNS Neurol Disord Drug Targets 11:395\u2013409","journal-title":"CNS Neurol Disord Drug Targets"},{"key":"1887_CR72","doi-asserted-by":"publisher","first-page":"100019","DOI":"10.1016\/j.dscb.2021.100019","volume":"3","author":"S Upadhayay","year":"2021","unstructured":"Upadhayay S, Mehan S (2021) Targeting Nrf2\/HO-1 anti-oxidant signaling pathway in the progression of multiple sclerosis and influences on neurological dysfunctions. Brain Disorders 3:100019","journal-title":"Brain Disorders"},{"key":"1887_CR73","doi-asserted-by":"publisher","first-page":"1324","DOI":"10.3390\/genes13081324","volume":"13","author":"S Upadhayay","year":"2022","unstructured":"Upadhayay S, Mehan S, Prajapati A, Sethi P, Suri M, Zawawi A, Almashjary MN, Tabrez S (2022) Nrf2\/HO-1 signaling stimulation through acetyl-11-keto-beta-boswellic acid (AKBA) provides neuroprotection in ethidium bromide-induced experimental model of multiple sclerosis. Genes 13:1324","journal-title":"Genes"},{"key":"1887_CR74","doi-asserted-by":"publisher","first-page":"e70413","DOI":"10.1002\/jbt.70413","volume":"39","author":"S Upadhayay","year":"2025","unstructured":"Upadhayay S, Soni D, Kumar P (2025) Raloxifene and Fulvestrant Exert Antioxidant, Anti-Inflammatory, and Antiapoptotic Action Against Haloperidol\u2010Induced Tardive Dyskinesia in Rats via Activation of the GPER1\/PI3k\/Akt\/Nrf2\/HO\u20101 Signaling Pathways. J Biochem Mol Toxicol 39:e70413","journal-title":"J Biochem Mol Toxicol"},{"key":"1887_CR75","doi-asserted-by":"publisher","first-page":"13574","DOI":"10.1523\/JNEUROSCI.4099-08.2008","volume":"28","author":"MR Vargas","year":"2008","unstructured":"Vargas MR, Johnson DA, Sirkis DW, Messing A, Johnson JA (2008) Nrf2 activation in astrocytes protects against neurodegeneration in mouse models of familial amyotrophic lateral sclerosis. J Neurosci 28:13574\u201313581","journal-title":"J Neurosci"},{"key":"1887_CR76","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1007\/s40265-020-01310-2","volume":"80","author":"N Vijiaratnam","year":"2020","unstructured":"Vijiaratnam N, Foltynie T (2020) Therapeutic strategies to treat or prevent off episodes in adults with Parkinson\u2019s disease. Drugs 80:775\u2013796","journal-title":"Drugs"},{"key":"1887_CR77","doi-asserted-by":"crossref","unstructured":"Weinstein DE (1997) Isolation and purification of primary rodent astrocytes. Curr Prot Neurosci 3.5. 1-3.5. 9","DOI":"10.1002\/0471142301.ns0305s00"},{"key":"1887_CR78","first-page":"9163040","volume":"2018","author":"M Weng","year":"2018","unstructured":"Weng M, Xie X, Liu C, Lim K-L, Zhang C-W, Li L (2018) The sources of reactive oxygen species and its possible role in the pathogenesis of Parkinson\u2019s disease. Parkinson\u2019s Disease 2018: 9163040","journal-title":"Parkinson\u2019s Dis"},{"key":"1887_CR79","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.biochi.2015.04.019","volume":"115","author":"Y Yang","year":"2015","unstructured":"Yang Y, Wang H, Lv X, Wang Q, Zhao H, Yang F, Yang Y, Li J (2015) Involvement of cAMP-PKA pathway in adenosine A1 and A2A receptor-mediated regulation of acetaldehyde-induced activation of HSCs. Biochimie 115:59\u201370","journal-title":"Biochimie"},{"key":"1887_CR80","doi-asserted-by":"crossref","unstructured":"Yankelevitch-Yahav R, Franko M, Huly A, Doron R (2015) The forced swim test as a model of depressive-like behavior. J Visual Exper JoVE 52587","DOI":"10.3791\/52587-v"},{"key":"1887_CR81","doi-asserted-by":"publisher","first-page":"1783","DOI":"10.1007\/s11033-020-05272-2","volume":"47","author":"M Zarei-Kheirabadi","year":"2020","unstructured":"Zarei-Kheirabadi M, Mirsadeghi S, Vaccaro AR, Rahimi-Movaghar V, Kiani S (2020) Protocol for purification and culture of astrocytes: useful not only in 2 days postnatal but also in adult rat brain. Mol Biol Rep 47:1783\u20131794","journal-title":"Mol Biol Rep"},{"key":"1887_CR82","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.1002\/cpt.1374","volume":"105","author":"KE Zeuner","year":"2019","unstructured":"Zeuner KE, Sch\u00e4ffer E, Hopfner F, Br\u00fcggemann N, Berg D (2019) Progress of pharmacological approaches in Parkinson\u2019s disease. Clin Pharmacol Ther 105:1106\u20131120","journal-title":"Clin Pharmacol Ther"},{"key":"1887_CR83","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.pneurobio.2012.09.003","volume":"100","author":"M Zhang","year":"2013","unstructured":"Zhang M, An C, Gao Y, Leak RK, Chen J, Zhang F (2013) Emerging roles of Nrf2 and phase II antioxidant enzymes in neuroprotection. Prog Neurobiol 100:30\u201347","journal-title":"Prog Neurobiol"},{"key":"1887_CR84","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.pbb.2015.02.020","volume":"132","author":"M Zygmunt","year":"2015","unstructured":"Zygmunt M, Go\u0142embiowska K, Drabczy\u0144ska A, Kie\u0107-Kononowicz K, Sapa J (2015) Anti-inflammatory, antioxidant, and antiparkinsonian effects of adenosine A2A receptor antagonists. Pharmacol Biochem Behav 132:71\u201378","journal-title":"Pharmacol Biochem Behav"}],"container-title":["Metabolic Brain Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11011-026-01887-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11011-026-01887-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11011-026-01887-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T10:02:35Z","timestamp":1779962555000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11011-026-01887-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,28]]},"references-count":84,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1887"],"URL":"https:\/\/doi.org\/10.1007\/s11011-026-01887-9","relation":{},"ISSN":["1573-7365"],"issn-type":[{"value":"1573-7365","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,28]]},"assertion":[{"value":"17 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All animal experiments were performed in accordance with the National Guidelines for the Care and Use of Laboratory Animals (Indian National Science Academy, New Delhi). The study protocol was approved by the Institutional Animal Ethics Committee (IAEC) of Dr. B. R. Ambedkar Center for Biomedical Research (ACBR), University of Delhi (Approval No. IAEC\/ACBR\/August 2023\/PML\/01).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Animal ethical approval"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"119"}}